FuRST 2.0 Cognitive Pre-Testing
FuRST 2.0: Cognitive Pre-Testing Study for a New Functional Rating Scale for Use in Huntington's Disease
Sponsor: CHDI Foundation, Inc.
Listed as NCT02881931, this observational or N/A phase trial focuses on Huntington's Disease and remains completed. Sponsored by CHDI Foundation, Inc., it has been updated 9 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
▶ Show 4 earlier versions
-
Aug 2017 — Apr 2018 [monthly]
Completed NA
Status: Recruiting → Completed
-
May 2017 — Aug 2017 [monthly]
Recruiting NA
-
Mar 2017 — May 2017 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2017 — Mar 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- CHDI Foundation, Inc.
- Dr. Glenn T. Stebbins (Rush University Medical Center )
- Nancy LaPelle
- The University of Texas Health Science Center, Houston
For direct contact, visit the study record on ClinicalTrials.gov .